Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evolution of HCV associated porphyria cutanea tarda after HCV sustained virologic response by direct acting antivirals.

Gastroenterologia y hepatologia - 1 Apr 2022

García-Fraile Lucio J, García-Buey Luisa, Alonso Cerezo Concepción, Sanz Sanz Jesús, de Los Santos Gil Ignacio

Abstract excerpt

OBJECTIVES: Porphyria cutanea tarda (PCT) is common and usually associated with HCV chronic infection and HFE polymorphisms. Since DAA IFN-free regimens availability, SVR for HCV is nearly a constant and we wonder whether HCV SVR determine PCT evolution. METHODS: Retrospective observational study including patients with HCV associated PCT from the Gastroenterology and Infectious Diseases Departments at our...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Hepatitis C

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Mutation

Share to Porphyria Cutanea Tarda

Share to Sustained Virologic Response

Source

Identifiers

PMID: 34562521
DOI: 10.1016/j.gastrohep.2021.09.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evolution of HCV associated porphyria cutanea tarda after HCV sustained virologic response by direct acting antivirals.PMID 34562521Read ↗

Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C.Semantic proximity Read ↗

Porphyria cutanea tarda as a complication of therapy for chronic hepatitis C.Semantic proximity Read ↗

Porphyria cutanea tarda as a predictor of poor response to interferon alfa therapy in chronic hepatitis C.Semantic proximity Read ↗

Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection.Semantic proximity Read ↗

Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients.Semantic proximity Read ↗

The porphyrias: advances in diagnosis and treatmentSemantic proximity Read ↗

Porphyria cutanea tarda in an HCV-positive liver transplant patient: a case report.Semantic proximity Read ↗

The porphyrias: advances in diagnosis and treatment.Semantic proximity Read ↗

The porphyrias: advances in diagnosis and treatment.Semantic proximity Read ↗

[Advances in the diagnosis and treatment of porphyria-related hepatic manifestations].Semantic proximity Read ↗

The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.Semantic proximity Read ↗

Porphyria Cutanea Tarda and Patterns of Long-term Sick Leave and Disability Pension: a 24-year Nationwide Matched Cohort StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.